Viridien
Short position disclosed on October 21, 2026.
10.49% of the capital sold short
9 disclosing funds
2,528 disclosures on record
Evolution of the disclosed total
0%5%10%15%
Jan 2026Apr 2026Jul 2026Oct 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Marshall Wace LLP | 1.99% | unchanged | October 20, 2026 | ||
| Capital Fund Management | 1.69% | new | October 19, 2026 | ||
| Citadel Advisors LLC | 1.46% | new | October 21, 2026 | ||
| Worldquant, LLC | 1.29% | new | October 15, 2026 | ||
| Acadian Asset Management LLC | 1.10% | new | October 19, 2026 | ||
| Tudor Capital Europe LLP | 0.80% | new | October 1, 2026 | ||
| Walleye Capital LLC | 0.80% | new | October 5, 2026 | ||
| TWO Sigma Investments, LP | 0.79% | new | October 19, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 15,164 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| November 30, 2021 | Marshall Wace LLP | 1.22% | May 13, 2022 | |
| November 29, 2021 | Marshall Wace LLP | 1.11% | May 13, 2022 | |
| November 29, 2021 | Qube Research & Technologies Limited | 0.60% | December 3, 2021 | |
| November 26, 2021 | Marshall Wace LLP | 1.07% | May 13, 2022 | |
| November 26, 2021 | Qube Research & Technologies Limited | 0.88% | December 3, 2021 | |
| November 26, 2021 | Citadel Europe LLP | 0.03% | November 30, 2021 | |
| November 24, 2021 | Citadel Europe LLP | 0.69% | November 30, 2021 | |
| November 24, 2021 | Qube Research & Technologies Limited | 0.56% | December 3, 2021 | |
| November 23, 2021 | Marshall Wace LLP | 0.98% | May 13, 2022 | |
| November 23, 2021 | Citadel Europe LLP | 0.77% | November 30, 2021 | |
| November 22, 2021 | Qube Research & Technologies Limited | 0.84% | December 3, 2021 | |
| November 22, 2021 | Numeric Investors LLC | 0.61% | February 3, 2022 | |
| November 19, 2021 | Citadel Europe LLP | 0.89% | November 30, 2021 | |
| November 18, 2021 | Marshall Wace LLP | 1.09% | May 13, 2022 | |
| November 18, 2021 | Citadel Europe LLP | 1.01% | November 30, 2021 | |
| November 18, 2021 | Qube Research & Technologies Limited | 0.76% | December 3, 2021 | |
| November 17, 2021 | Qube Research & Technologies Limited | 0.64% | December 3, 2021 | |
| November 16, 2021 | Citadel Europe LLP | 1.18% | November 30, 2021 | |
| November 15, 2021 | Citadel Europe LLP | 1.23% | November 30, 2021 | |
| November 15, 2021 | Marshall Wace LLP | 1.13% | May 13, 2022 | |
| November 15, 2021 | Numeric Investors LLC | 0.53% | February 3, 2022 | |
| November 12, 2021 | Citadel Europe LLP | 1.33% | November 30, 2021 | |
| November 12, 2021 | Qube Research & Technologies Limited | 0.75% | December 3, 2021 | |
| November 11, 2021 | Citadel Europe LLP | 1.47% | November 30, 2021 | |
| November 11, 2021 | Qube Research & Technologies Limited | 0.62% | December 3, 2021 | |
| November 10, 2021 | Citadel Europe LLP | 1.54% | November 30, 2021 | |
| November 10, 2021 | Marshall Wace LLP | 1.04% | May 13, 2022 | |
| November 10, 2021 | Qube Research & Technologies Limited | 0.58% | December 3, 2021 | |
| November 9, 2021 | Citadel Europe LLP | 1.78% | November 30, 2021 | |
| November 5, 2021 | Marshall Wace LLP | 0.94% | May 13, 2022 | |
| November 5, 2021 | Citadel Advisors LLC | 0.39% | November 9, 2021 | |
| November 4, 2021 | Citadel Europe LLP | 2.14% | November 30, 2021 | |
| November 4, 2021 | Qube Research & Technologies Limited | 0.66% | December 3, 2021 | |
| November 4, 2021 | Citadel Advisors LLC | 0.55% | November 9, 2021 | |
| October 28, 2021 | Citadel Europe LLP | 2.28% | November 30, 2021 | |
| October 28, 2021 | Qube Research & Technologies Limited | 0.72% | December 3, 2021 | |
| October 28, 2021 | Citadel Advisors LLC | 0.67% | November 9, 2021 | |
| October 27, 2021 | Citadel Europe LLP | 2.49% | November 30, 2021 | |
| October 27, 2021 | Marshall Wace LLP | 1.06% | May 13, 2022 | |
| October 26, 2021 | Citadel Europe LLP | 2.51% | November 30, 2021 | |
| October 26, 2021 | Citadel Advisors LLC | 0.77% | November 9, 2021 | |
| October 25, 2021 | Citadel Europe LLP | 2.96% | November 30, 2021 | |
| October 22, 2021 | Citadel Advisors LLC | 0.92% | November 9, 2021 | |
| October 21, 2021 | Citadel Advisors LLC | 0.89% | November 9, 2021 | |
| October 20, 2021 | Citadel Europe LLP | 3.17% | November 30, 2021 | |
| October 20, 2021 | Marshall Wace LLP | 1.10% | May 13, 2022 | |
| October 20, 2021 | Citadel Advisors LLC | 0.75% | November 9, 2021 | |
| October 19, 2021 | Marshall Wace LLP | 1.00% | May 13, 2022 | |
| October 15, 2021 | Marshall Wace LLP | 0.93% | May 13, 2022 | |
| October 14, 2021 | Citadel Advisors LLC | 1.27% | November 9, 2021 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 2,528 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.60% of the capital sold short
- Valeo 11.47% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- FDJ United 6.58% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.53% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.73% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
- Gecina 3.32% of the capital sold short
- Forvia 3.25% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at October 21, 2026, https://www.quivad.com/action/viridien?page=22